1-Bromo-2-(chloromethyl)-4,5-diethoxybenzene

Catalog No.: 
ACCLTP097
CAS No.: 
851116-19-3
Molecular Formula: 
C11H14BrClO2
Molecular Weight: 
293.59
1-Bromo-2-(chloromethyl)-4,5-diethoxybenzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$100.00InquiryInquiry
100mg95%$141.00InquiryInquiry
250mg95%$195.00InquiryInquiry
1g95%$480.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Bromo-2-(chloromethyl)-4,5-diethoxybenzene
IUPAC Name1-bromo-2-(chloromethyl)-4,5-diethoxybenzene
MDL No.MFCD06655801
Molecular FormulaC11H14BrClO2
Molecular Weight293.59
SMILESCCOC1=C(OCC)C=C(CCl)C(Br)=C1
InChI KeyLLKGGFRVYUNUPJ-UHFFFAOYSA-N
Synonym1-BROMO-2-(CHLOROMETHYL)-4,5-DIETHOXYBENZENE;Benzene, 1-bromo-2-(chloromethyl)-4,5-diethoxy-
CAS No.851116-19-3

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H290-H314
Precautionary Statement(s)
P234-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P390-P405-P406-P501

Synthetic Route by SureRoute

1. ACCLTP097 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCLTP097 route product structure diagram
    ACCLTP097851116-19-3
Inquiry

2. ACCLTP097 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCLTP097 route product structure diagram
    ACCLTP097851116-19-3
Inquiry

3. ACCLTP097 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCLTP097 route product structure diagram
    ACCLTP097851116-19-3
Inquiry

Comments (0)